IMR90 ER:RAS: A cell model of oncogene-induced senescence

5Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Oncogene-induced senescence (OIS) is a cellular response that limits the replication of cells expressing oncogenes. As a result, OIS is a potent tumor suppressor mechanism limiting cancer progression. Here we describe IMR90 ER:RAS, a widely used model to study OIS in cell culture. This model takes advantage of IMR90 human primary fibroblast infected with a 4-hydroxy-tamoxifen (4-OHT) inducible ER:RAS construct. RAS activation upon 4-OHT treatment results in a coordinated induction of senescence, recapitulating different aspects of the phenotype such as the growth arrest and the establishment of a senescence-associated secretory phenotype (SASP).

Cite

CITATION STYLE

APA

Innes, A. J., & Gil, J. (2019). IMR90 ER:RAS: A cell model of oncogene-induced senescence. In Methods in Molecular Biology (Vol. 1896, pp. 83–92). Humana Press Inc. https://doi.org/10.1007/978-1-4939-8931-7_9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free